Stökkva yfir í aðalyfirlit Stökkva yfir í leit Stökkva yfir í aðalefni

XA polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway

  • Christian Praetorius
  • , Christine Grill
  • , Simon N. Stacey
  • , Alexander M. Metcalf
  • , David U. Gorkin
  • , Kathleen C. Robinson
  • , Eric Van Otterloo
  • , Reuben S.Q. Kim
  • , Kristin Bergsteinsdottir
  • , Margret H. Ogmundsdottir
  • , Erna Magnusdottir
  • , Pravin J. Mishra
  • , Sean R. Davis
  • , Theresa Guo
  • , M. Raza Zaidi
  • , Agnar S. Helgason
  • , Martin I. Sigurdsson
  • , Paul S. Meltzer
  • , Glenn Merlino
  • , Valerie Petit
  • Lionel Larue, Stacie K. Loftus, David R. Adams, Ulduz Sobhiafshar, N. C.Tolga Emre, William J. Pavan, Robert Cornell, Aaron G. Smith, Andrew S. McCallion, David E. Fisher, Kari Stefansson, Richard A. Sturm, Eirikur Steingrimsson

Rannsóknarafurð: Framlag til fræðitímaritsGreinritrýni

Útdráttur

Sequence polymorphisms linked to human diseases and phenotypes in genome-wide association studies often affect noncoding regions. A SNP within an intron of the gene encoding Interferon Regulatory Factor 4 (IRF4), a transcription factor with no known role in melanocyte biology, is strongly associated with sensitivity of skin to sun exposure, freckles, blue eyes, and brown hair color. Here, we demonstrate that this SNP lies within an enhancer of IRF4 transcription in melanocytes. The allele associated with this pigmentation phenotype impairs binding of the TFAP2A transcription factor that, together with the melanocyte master regulator MITF, regulates activity of the enhancer. Assays in zebrafish and mice reveal that IRF4 cooperates with MITF to activate expression of Tyrosinase (TYR), an essential enzyme in melanin synthesis. Our findings provide a clear example of a noncoding polymorphism that affects a phenotype by modulating a developmental gene regulatory network.

Upprunalegt tungumálEnska
Síður (frá-til)1022-1033
FræðitímaritCell
Bindi155
Númer tölublaðs5
DOI
ÚtgáfustaðaÚtgefið - 21 nóv. 2013

Athugasemd

Funding Information: We thank Thorunn Rafnar, Magnus Karl Magnusson, Unnur Thorsteinsdottir, Colin R. Goding, and Thorarinn Gudjonsson for critical comments on the manuscript. This work was supported by grants from NIH (5R01 AR043369-16), Melanoma Research Alliance, Dr. Miriam and Sheldon Adelson Medical Research Foundation, US-Israel Binational Science Foundation (to D.E.F.), Ligue Nationale Contre le Cancer (Equipe labellisée) and INCa (to L.L.), the Icelandic Research Fund and the Research Fund of the University of Iceland (to E.S.), the Haskolasjodur Student Fund (to E.S., C.P., and C.G.), the Jules Verne Fund (to E.S. and L.L.), by the National Institute of General Medical Sciences (GM071648) and National Institute of Neurological Disease and Stroke (NS062972; to A.S.M.), the National Human Genome Research Institute’s Intramural Research Program (to W.J.P. and S.L.), and an NSF Graduate Research Fellowship (to D.U.G.).

Fingerprint

Sökktu þér í rannsóknarefni „XA polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway“. Saman myndar þetta einstakt fingrafar.

Vitna í þetta